IRIS
PINCHERA, BIAGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.004
EU - Europa 595
AS - Asia 302
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 978
IT - Italia 286
SG - Singapore 217
DE - Germania 125
NL - Olanda 97
CN - Cina 53
CI - Costa d'Avorio 28
CA - Canada 25
CH - Svizzera 20
IN - India 19
GB - Regno Unito 16
FI - Finlandia 10
RU - Federazione Russa 10
FR - Francia 9
IE - Irlanda 6
UA - Ucraina 6
EG - Egitto 4
VN - Vietnam 4
AT - Austria 3
HK - Hong Kong 3
LT - Lituania 3
SE - Svezia 3
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
EU - Europa 1
JO - Giordania 1
NI - Nicaragua 1
PK - Pakistan 1
Totale 1.935
Salva come PNG Salva come JPEG
Città #
Singapore 169
Ashburn 167
Naples 134
Chandler 127
Santa Clara 111
Amsterdam 96
Lawrence 33
Krefeld 32
Millbury 32
Des Moines 23
Boston 19
Rome 19
Basel 17
Boardman 17
Napoli 17
Seattle 15
Washington 15
Ottawa 13
Wilmington 10
Beijing 9
Formia 9
Milan 9
Pozzuoli 9
Pune 9
Kronberg 8
Los Angeles 7
Marseille 6
Helsinki 5
Bologna 4
Council Bluffs 4
Dong Ket 4
Dublin 4
Lappeenranta 4
Munich 4
Dallas 3
Fairfield 3
Frankfurt am Main 3
Hong Kong 3
Jiaxing 3
Mariglianella 3
Melito di Napoli 3
Moscow 3
Nanjing 3
Richmond 3
Salerno 3
Shanghai 3
Shijiazhuang 3
Alcamo 2
Bern 2
Cairo 2
Caserta 2
Changsha 2
Hanover 2
Houston 2
Hyderabad 2
London 2
Paris 2
Prato 2
Shenyang 2
Smithtown 2
Tianjin 2
Tokyo 2
Toronto 2
Torre del Greco 2
Zhengzhou 2
Abidjan 1
Amman 1
Baku 1
Bari 1
Bayreuth 1
Boydton 1
Brussels 1
Cardito 1
Cava 1
Cava De' Tirreni 1
Changzhou 1
Chengdu 1
Chinandega 1
Clifton 1
Crispano 1
Desio 1
Dubai 1
Ercolano 1
Fisciano 1
Foggia 1
Forest City 1
Gragnano 1
Harbin 1
Hebei 1
Jinhua 1
La Canada Flintridge 1
Melbourne 1
Monteforte Irpino 1
Montreal 1
Nanchang 1
New York 1
Ningbo 1
Norwalk 1
Nuremberg 1
Palermo 1
Totale 1.271
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 133
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 54
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 46
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 45
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 45
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 44
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 42
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 42
Current evidence on the management of hepatitis B in pregnancy 41
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 40
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 40
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 39
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 38
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 37
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 37
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 36
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 35
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 35
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 33
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients 33
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 33
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 32
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 31
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 31
Further findings concerning endothelial damage in covid-19 patients 31
Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients 30
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 29
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 28
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 28
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 27
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 26
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 26
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 26
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 26
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension 26
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 26
Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy? 26
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 25
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 24
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 24
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 23
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 23
No Detection of SARS-CoV-2 RNA on Urethral Swab in Patients with Positive Nasopharyngeal Swab 23
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 23
Diabetes and COVID-19: The potential role of mTOR 22
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia 22
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 22
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 21
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 20
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 20
Soluble urokinase receptor as a promising marker for early prediction of outcome in covid-19 hospitalized patients 20
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 19
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 19
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 19
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 19
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 19
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 19
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 18
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 18
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 17
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 17
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 15
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 15
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 15
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 14
Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives 12
Molecular fingerprint by omics‐based approaches in saliva from patients affected by SARS‐CoV‐2 infection 11
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 10
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 10
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 10
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 10
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 9
Update on the Management of Surgical Site Infections 9
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 8
Immune Profile in COVID-19: Unveiling TR3-56 Cells in SARS-CoV-2 Infection 8
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 8
Alzheimer's disease and herpes viruses: Current events and perspectives 7
Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases 7
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Series 6
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 6
Preventing sepsis development in complicated urinary tract infections 6
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy 5
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 5
Bulevirtide Treatment of Hepatitis Delta Virus Infection in a Kidney Transplant Recipient: A Case Report 3
Urinary Tract Infections in Kidney Transplant Patients: An Open Challenge—Update on Epidemiology, Risk Factors and Management 3
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 2
Infection prevention and control risk factors for SARS-CoV-2 infection in health workers: a global, multi-centre, case–control study 2
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 1
Personalized care approaches to hepatitis C therapy: recent advances and future directions 1
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 1
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study 1
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 1
COVID-19 in solid organ transplant recipients after 2 years of pandemic: Outcome and impact of antiviral treatments in a single-center study 1
Totale 2.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 1 3 2 1 2 12 3
2020/202174 5 1 2 2 18 1 16 5 9 6 5 4
2021/2022224 11 2 3 1 1 5 8 19 8 27 58 81
2022/2023653 35 22 20 21 59 75 38 166 72 102 33 10
2023/2024604 22 78 104 48 46 108 9 55 20 9 59 46
2024/2025476 84 47 19 75 92 159 0 0 0 0 0 0
Totale 2.095